PU14.01 Virological failure is consistent with acquired HIV drug resistance among adolescents living with perinatal HIV infection: evidence from the EDCTP-READY studyPublication OnlyHIV sequencing insights including viral diversity and antiretroviral resistance
PE29.02 Viral Suppression and CD4 counts with transition to TDF/3TC/DTG (TLD)E-posterTransmission of HIV
PE02.04 Variation in neutralization susceptibility of HIV-1 Indian subtype C to potent and broadly neutralizing monoclonal antibodies (bnAbs) having distinct epitope specificitiesE-posterBroadly neutralizing antibodies
PE11.06 Variables predictive of HIV seroconversion among sub-Saharan African heterosexual women: a systematic reviewE-posterEpidemiology of HIV
PE28.02 Variable HIV seroincidence rates in a cohort of high-risk men who have sex with men (MSM) and transgender women (TGW) in ChinaE-posterTransmission of HIV
PU01.14 Validating tools to screen for and monitor oral PrEP adherencePublication OnlyBehavioural and social science research
PE16.03 Validating HEART: a HEAlthy relationships assessment tool for PrEP useE-posterImplementation science, including structural interventions, PrEP & VMMC
PU20.01 Vaccination with Ad26.ZEBOV, MVA-BN-Filo or MVA-BN-Filo, Ad26.ZEBOV induced predominantly IgG binding to Ebola glycoprotein in cervico-vaginal mucus in HIV-infected and uninfected participantsPublication OnlyMucosal immunity
OA08.02 Vaccination induces maturation of diverse unmutated VRC01-class precursors to HIV-1 broadly neutralizing antibodies in an Ig-humanized mouse modelOral Abstract SessionBroadly neutralizing antibodies
OA13.05LB Utilizing a robust HIV prevention community engagement framework to engage communities in COVID-19 prevention effortsOral Abstract SessionCommunity engagement in prevention research
seek-warrow-warrow-eseek-e11 - 20 of 444 items